Vaxart Merger, page-20

OK. I'm going to say it. I don't know why, and you guys should talk me out of it, and maybe then someone should come and take me to the psychiatrist for medication, but....is it possible that Vaxart is a buy? Of course it can't be because anything that touches Biota is cursed. Bad people making bad choices.

But in terms of valuation based on the technology, it seems undervalued. There's tiny value attributed to its technology in the shareprice. And even if it ultimately fails, there appears to be an opportunity to ride the next few news cycles.

And maybe all those hedge funds and institutions who were burned with aviragen will decide that with the executive team of aviragen gone, it might be worth another look.

Please, please, make these thoughts go away.